Skip to main content
Top
Published in: Immunity & Ageing 1/2016

Open Access 01-12-2016 | Short report

Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults

Authors: Marco Grasse, Andreas Meryk, Michael Schirmer, Beatrix Grubeck-Loebenstein, Birgit Weinberger

Published in: Immunity & Ageing | Issue 1/2016

Login to get access

Abstract

We have recently demonstrated that single shot vaccinations against tetanus and diphtheria do not lead to long-lasting immunity against diphtheria in elderly persons despite administration at 5 year intervals. In the present study we have immunized a group of young adults against tetanus and diphtheria to compare the pre- and 28 days post-vaccination immune responses in the young group with results of the same vaccination performed in an elderly group of a previous study. We also studied protection in both groups 5 years after vaccination. We compared antibody titers at all three time points and also analyzed the T cell responses in both age groups 5 years after vaccination.
Before vaccination 9 % of the elderly persons were not protected against tetanus, and 48 % did not have protection against diphtheria. In the young group all participants were protected against tetanus, but 52 % were also unprotected against diphtheria before vaccination. 28 days after vaccination 100 % of all participants had protective antibody concentrations against tetanus and only a small percentage in each age group (<10 %) was unprotected against diphtheria. 5 years later, 100 % of both cohorts were still protected against tetanus, but 24 % of the young and 54 % of the elderly group were unprotected against diphtheria. Antibody concentrations against diphtheria measured by ELISA correlated well with their neutralizing capacity. T cell responses to tetanus and diphtheria did not differ between young and old persons. We conclude that booster vaccinations against tetanus and diphtheria according to present recommendations provide long-lasting protection only against tetanus, but not against diphtheria, independently of age. In elderly persons, the level of protection is even lower, probably due to intrinsic age-related changes within the immune system and/or insufficient vaccination earlier in life.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol. 1995;11:95–105.CrossRefPubMed Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol. 1995;11:95–105.CrossRefPubMed
3.
go back to reference World Health Organization. Tetanus Vaccine-WHO position paper. Wkly Epidemiol Rec. 2006;81:198–208. World Health Organization. Tetanus Vaccine-WHO position paper. Wkly Epidemiol Rec. 2006;81:198–208.
4.
go back to reference World Health Organization. Diphtheria Vaccine-WHO position paper. Wkly Epidemiol Rec. 2006;81:24–31. World Health Organization. Diphtheria Vaccine-WHO position paper. Wkly Epidemiol Rec. 2006;81:24–31.
6.
go back to reference Bayas JM, Vilella A, Bertran MJ, Vidal J, Batalla J, Asenjo MA, et al. Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary. Epidemiol Infect. 2001;127:451–60.PubMedPubMedCentral Bayas JM, Vilella A, Bertran MJ, Vidal J, Batalla J, Asenjo MA, et al. Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary. Epidemiol Infect. 2001;127:451–60.PubMedPubMedCentral
7.
go back to reference Launay O, Toneatti C, Bernede C, Njamkepo E, Petitprez K, Leblond A, et al. Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations. Hum Vaccin. 2009;5:341–6.CrossRefPubMed Launay O, Toneatti C, Bernede C, Njamkepo E, Petitprez K, Leblond A, et al. Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations. Hum Vaccin. 2009;5:341–6.CrossRefPubMed
10.
go back to reference van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine. 2004;22:305–8.CrossRefPubMed van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine. 2004;22:305–8.CrossRefPubMed
11.
go back to reference Kaml M, Weiskirchner I, Keller M, Luft T, Hoster E, Hasford J, et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine. 2006;24:6808–11. doi:10.1016/j.vaccine.2006.06.037.CrossRefPubMed Kaml M, Weiskirchner I, Keller M, Luft T, Hoster E, Hasford J, et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine. 2006;24:6808–11. doi:10.​1016/​j.​vaccine.​2006.​06.​037.CrossRefPubMed
14.
go back to reference Vesikari T, Silfverdal SA, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age. Clin Vaccine Immunol. 2013;20:1647–53. doi:10.1128/CVI.00414-13.CrossRefPubMedPubMedCentral Vesikari T, Silfverdal SA, Boisnard F, Thomas S, Mwawasi G, Reynolds D. Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age. Clin Vaccine Immunol. 2013;20:1647–53. doi:10.​1128/​CVI.​00414-13.CrossRefPubMedPubMedCentral
15.
16.
go back to reference Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T, et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012;30:2647–53. doi:10.1016/j.vaccine.2012.02.013.CrossRefPubMed Tomovici A, Barreto L, Zickler P, Meekison W, Noya F, Voloshen T, et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 2012;30:2647–53. doi:10.​1016/​j.​vaccine.​2012.​02.​013.CrossRefPubMed
17.
go back to reference Gupta RK, Relyveld EH. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. Vaccine. 1991;9:699–702.CrossRefPubMed Gupta RK, Relyveld EH. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. Vaccine. 1991;9:699–702.CrossRefPubMed
18.
go back to reference Galazka AM, Robertson SE. Immunization against diphtheria with special emphasis on immunization of adults. Vaccine. 1996;14:845–57.CrossRefPubMed Galazka AM, Robertson SE. Immunization against diphtheria with special emphasis on immunization of adults. Vaccine. 1996;14:845–57.CrossRefPubMed
19.
go back to reference Relyveld EH, Bizzini B, Gupta RK. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine. 1998;16:1016–23.CrossRefPubMed Relyveld EH, Bizzini B, Gupta RK. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine. 1998;16:1016–23.CrossRefPubMed
21.
go back to reference Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng N, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011;121:3109–19. doi:10.1172/JCI57834.CrossRefPubMedPubMedCentral Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng N, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011;121:3109–19. doi:10.​1172/​JCI57834.CrossRefPubMedPubMedCentral
26.
go back to reference Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, et al. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice. Cell Mol Immunol. 2015. doi: 10.1038/cmi.2015.64. Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, et al. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice. Cell Mol Immunol. 2015. doi: 10.​1038/​cmi.​2015.​64.
27.
go back to reference Follador I, Araujo C, Orge G, Cheng LH, de Carvalho LP, Bacellar O, et al. Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor. Vaccine. 2002;20:1365–8.CrossRefPubMed Follador I, Araujo C, Orge G, Cheng LH, de Carvalho LP, Bacellar O, et al. Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor. Vaccine. 2002;20:1365–8.CrossRefPubMed
Metadata
Title
Booster vaccination against tetanus and diphtheria: insufficient protection against diphtheria in young and elderly adults
Authors
Marco Grasse
Andreas Meryk
Michael Schirmer
Beatrix Grubeck-Loebenstein
Birgit Weinberger
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2016
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/s12979-016-0081-0

Other articles of this Issue 1/2016

Immunity & Ageing 1/2016 Go to the issue